OBJECTIVE	Patients in most trials of pharmacotherapy for nonorganic dyspepsia have been groups referred selectively for endoscopy , which could have led to a selection bias of nonresponders , explaining the negative outcome of most controlled treatment trials in nonorganic dyspepsia .\